RecruitingNot ApplicableNCT06066918

Prophylactic Pregabalin Treatment Following Spinal Cord Injury

The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain

Sponsor

Loewenstein Hospital

Enrollment

50 participants

Start Date

Jul 13, 2021

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injuries Spinal Cord Diseases

Summary

Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Pregabalin 75mg for people with spinal cord diseases and spinal cord injuries. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.